Company / Operating Cash Flow per Share
MBX Biosciences, Inc. Operating Cash Flow per Share History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$5.14
FY2024
5-year range
-$31.39 / -$5.14
FY2023-FY2024
Trend
+83.6%
vs FY2023
Sector context
#200 of 212
Health Care
What the data says
Among 212 Health Care companies, MBX Biosciences, Inc. is in the bottom 6% for operating cash flow per share.
Based on SEC 10-K filings.
-5.14 in FY2024.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 212This company -$5.14 Sector average -$14.72
▼
+65.1% above sector average
Key checks
Key Insights
- In FY2024, operating cash flow per share increased 83.6% year-over-year.
- Ranks #200 out of 212 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 9.64 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$5.14 | +83.6% |
| FY2023 | -$31.39 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026